Votrient
Generic name: Pazopanib
Drug class:
VEGF/VEGFR inhibitors
Usage of Votrient
Votrient is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Pazopanib is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Votrient is used to treat advanced renal cell carcinoma (kidney cancer).
Votrient is also used to treat soft tissue sarcoma (a tumor that can develop in or around muscles, tendons, joints, organs, or blood vessels).
Votrient is usually given after other cancer medications have been tried without successful treatment of soft tissue sarcoma.
Votrient side effects
Get emergency medical help if you have signs of an allergic reaction to Votrient: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor or get emergency medical help if you have signs of dangerously high blood pressure: severe chest pain, severe headache, blurred vision, pounding in your neck or ears, anxiety, shortness of breath, or feeling like you might pass out.
Call your doctor at once if you have:
Liver problems may be more likely in adults older than 65.
Common Votrient side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Votrient
To make sure Votrient is safe for you, tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
Do not use Votrient if you are pregnant. It could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 2 weeks after your last dose.
If you are a man whose sex partner is pregnant or could become pregnant, use condoms while taking Votrient, and for at least 2 weeks after your last dose. You should use condoms even if you have had a vasectomy.
You should not breastfeed while you are using Votrient, and for at least 2 weeks after your last dose.
Relate drugs
- Alymsys
- Alymsys (Bevacizumab Intravenous)
- Alymsys (Bevacizumab-maly Intravenous)
- Avastin
- Cyramza
- Mvasi
- Mvasi (Bevacizumab Intravenous)
- Mvasi (Bevacizumab-awwb Intravenous)
- Bevacizumab
- Bevacizumab-adcd
- Bevacizumab-awwb
- Bevacizumab-bvzr
- Bevacizumab-maly
- Fotivda
- Pazopanib
- Ramucirumab
- Tivozanib
- Vegzelma
- Vegzelma (Bevacizumab Intravenous)
- Vegzelma (Bevacizumab-adcd Intravenous)
- Votrient
- Zaltrap
- Zirabev
- Zirabev (Bevacizumab Intravenous)
- Zirabev (Bevacizumab-bvzr Intravenous)
- Ziv-aflibercept
How to use Votrient
Usual Adult Dose for Renal Cell Carcinoma:
800 mg orally once a day without food, at least 1 hour before or 2 hours after a meal Comments: -Limitation of Use: The efficacy of the drug for adipocytic soft tissue sarcoma or gastrointestinal stromal tumors has not been demonstrated. -Dose should not exceed 800 mg. -Swallow tablets whole with water; do not break or crush due to potential for increased rate of absorption which may affect systemic exposure. -Do not take missed dose if less than 12 hours until the next dose. -Avoid grapefruit or grapefruit juice as it may increase plasma concentration of the drug. -There is no specific antidote for overdosage of the drug. Treatment should consist of general supportive measures. Uses: Advanced renal cell carcinoma (RCC), advanced soft tissue sarcoma (STS) with prior chemotherapy
Usual Adult Dose for Soft Tissue Sarcoma:
800 mg orally once a day without food, at least 1 hour before or 2 hours after a meal Comments: -Limitation of Use: The efficacy of the drug for adipocytic soft tissue sarcoma or gastrointestinal stromal tumors has not been demonstrated. -Dose should not exceed 800 mg. -Swallow tablets whole with water; do not break or crush due to potential for increased rate of absorption which may affect systemic exposure. -Do not take missed dose if less than 12 hours until the next dose. -Avoid grapefruit or grapefruit juice as it may increase plasma concentration of the drug. -There is no specific antidote for overdosage of the drug. Treatment should consist of general supportive measures. Uses: Advanced renal cell carcinoma (RCC), advanced soft tissue sarcoma (STS) with prior chemotherapy
Warnings
You should not use Votrient if you have severe liver disease. Pazopanib can cause severe or life-threatening liver problems. You will need frequent blood tests to check your liver function.
Call your doctor at once if you have: nausea, vomiting, upper stomach pain, loss of appetite, tiredness, easy bruising, dark urine, or jaundice (yellowing of the skin or eyes).
Votrient can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).
What other drugs will affect Votrient
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact wth pazopanib, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions